Biodesix, Inc.
BDSX
$0.4266
-$0.0198-4.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.68% | 21.19% | 39.28% | 34.54% | 50.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.68% | 21.19% | 39.28% | 34.54% | 50.99% |
| Cost of Revenue | 3.97% | 16.63% | 28.69% | 29.42% | 19.73% |
| Gross Profit | 13.80% | 22.43% | 42.44% | 36.15% | 62.71% |
| SG&A Expenses | 13.99% | -0.53% | 24.42% | 29.17% | 18.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.86% | 4.85% | 25.38% | 29.42% | 14.46% |
| Operating Income | -18.64% | 17.26% | 4.38% | -19.79% | 25.23% |
| Income Before Tax | -6.11% | 18.46% | 9.72% | 6.31% | 19.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.11% | 18.46% | 9.72% | 6.31% | 19.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.11% | 18.46% | 9.72% | 6.31% | 19.08% |
| EBIT | -18.64% | 17.26% | 4.38% | -19.79% | 25.23% |
| EBITDA | -22.18% | 20.04% | 13.15% | -11.10% | 33.37% |
| EPS Basic | 8.00% | 45.90% | 43.13% | 48.98% | 50.03% |
| Normalized Basic EPS | 5.43% | 46.04% | 43.76% | 49.01% | 51.46% |
| EPS Diluted | 8.00% | 45.90% | 43.13% | 48.98% | 50.03% |
| Normalized Diluted EPS | 5.43% | 46.04% | 43.76% | 49.01% | 51.46% |
| Average Basic Shares Outstanding | 15.32% | 50.82% | 58.79% | 83.54% | 61.99% |
| Average Diluted Shares Outstanding | 15.32% | 50.82% | 58.79% | 83.54% | 61.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |